To determine whether PD-L1 is associated with bladder cancer radiosensitivity in vivo, MB49 tumour cells were implanted, and 14 days later, the tumours were treated with RT (12 Gy) with or without anti–PD-L1. The gene discussed is CD274; the disease is urinary bladder cancer.